199 related articles for article (PubMed ID: 34257605)
1. Three Dimensional Cell Culturing for Modeling Adrenal and Pituitary Tumors.
Krokker L; Szabó B; Németh K; Tóháti R; Sarkadi B; Mészáros K; Patócs A; Butz H
Pathol Oncol Res; 2021; 27():640676. PubMed ID: 34257605
[No Abstract] [Full Text] [Related]
2. Concurrent pheochromocytoma and cortical carcinoma of the adrenal gland.
Fassina A; Cappellesso R; Schiavi F; Fassan M
J Surg Oncol; 2011 Jan; 103(1):103-4. PubMed ID: 21031430
[No Abstract] [Full Text] [Related]
3. Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.
Strosberg JR
Semin Oncol; 2013 Feb; 40(1):120-33. PubMed ID: 23391119
[TBL] [Abstract][Full Text] [Related]
4. Primary adrenal tumors--a 16-year experience in a single institution.
Białas M; Okoń K; Stachura J
Pol J Pathol; 2008; 59(2):101-6. PubMed ID: 18669176
[TBL] [Abstract][Full Text] [Related]
5. [A case of adrenal pheochromocytoma with contralateral adrenocortical adenoma].
Yotsuyanagi S; Fuse H; Koshida K; Uchibayashi T; Namiki M
Hinyokika Kiyo; 2001 Feb; 47(2):89-93. PubMed ID: 11280892
[TBL] [Abstract][Full Text] [Related]
6. Inflammation in the neoplasms of the adrenal gland: Is there a prognostic role? An immunohistochemical study.
Guadagno E; Russo D; Pignatiello S; Del Basso De Caro M
Pathol Res Pract; 2020 Sep; 216(9):153070. PubMed ID: 32825943
[TBL] [Abstract][Full Text] [Related]
7. A 3D adrenocortical carcinoma tumor platform for preclinical modeling of drug response and matrix metalloproteinase activity.
Dedhia PH; Sivakumar H; Rodriguez MA; Nairon KG; Zent JM; Zheng X; Jones K; Popova LV; Leight JL; Skardal A
Sci Rep; 2023 Sep; 13(1):15508. PubMed ID: 37726363
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells.
Willenberg HS; Haase M; Papewalis C; Schott M; Scherbaum WA; Bornstein SR
Neuroendocrinology; 2005; 82(5-6):274-81. PubMed ID: 16721033
[TBL] [Abstract][Full Text] [Related]
9. [Tumors of the adrenal glands : Update].
Saeger W; Komminoth P
Pathologe; 2019 Jul; 40(4):467-492. PubMed ID: 31250089
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of FSH receptors in pituitary adenomas and adrenal tumors.
Pawlikowski M; Pisarek H; Kubiak R; Jaranowska M; Stępień H
Folia Histochem Cytobiol; 2012 Oct; 50(3):325-30. PubMed ID: 23042261
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of survivin and PTEN in adrenal tumors].
Qin ZK; Zhou FJ; Dai YP; Chen W; Hou JH; Han H; Liu ZW; Yu SL; Zhang DZ; Yang JA
Ai Zheng; 2007 Oct; 26(10):1143-7. PubMed ID: 17927889
[TBL] [Abstract][Full Text] [Related]
12. Adrenal cortical adenoma with adrenalin-type neurosecretory granules clinically mimicking a pheochromocytoma.
Ivsic T; Komorowski RA; Sudakoff GS; Wilson SD; Datta MW
Arch Pathol Lab Med; 2002 Dec; 126(12):1530-3. PubMed ID: 12456217
[TBL] [Abstract][Full Text] [Related]
13. Positional statement of the European Society of Endocrine Surgeons (ESES) on malignant adrenal tumors.
Henry JF; Peix JL; Kraimps JL
Langenbecks Arch Surg; 2012 Feb; 397(2):145-6. PubMed ID: 22203016
[No Abstract] [Full Text] [Related]
14. [Morphometric characteristics of the cells in non-tumoral processes and tumors of the adrenal glands].
Smol'ianinova NV; Shapiro NA; Isakov VL
Lab Delo; 1989; (11):51-4. PubMed ID: 2481104
[TBL] [Abstract][Full Text] [Related]
15. [Adrenocortical tumors with neuroendocrine differentiation].
Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
[TBL] [Abstract][Full Text] [Related]
16. p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.
Sekiya T; Bronstein MD; Benfini K; Longuini VC; Jallad RS; Machado MC; Goncalves TD; Osaki LH; Higashi L; Viana J; Kater C; Lee M; Molatore S; Francisco G; Chammas R; Naslavsky MS; Schlesinger D; Gama P; Duarte YA; Lebrão ML; Zatz M; Meirelles O; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
Endocr Relat Cancer; 2014 Jun; 21(3):395-404. PubMed ID: 24532476
[TBL] [Abstract][Full Text] [Related]
17. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line.
Logié A; Boulle N; Gaston V; Perin L; Boudou P; Le Bouc Y; Gicquel C
J Mol Endocrinol; 1999 Aug; 23(1):23-32. PubMed ID: 10425444
[TBL] [Abstract][Full Text] [Related]
18. The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland.
Martinelli S; Cantini G; Propato AP; Bani D; Guasti D; Nardini P; Calosi L; Mello T; Bechmann N; Danza G; Villanelli F; Canu L; Maggi M; Mannelli M; Rapizzi E; Luconi M
Sci Rep; 2024 Apr; 14(1):8044. PubMed ID: 38580769
[TBL] [Abstract][Full Text] [Related]
19. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
Ichijo T; Ueshiba H; Nawata H; Yanase T
Endocr J; 2020 Feb; 67(2):141-152. PubMed ID: 31694993
[TBL] [Abstract][Full Text] [Related]
20. Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R.
Lichtenauer UD; Shapiro I; Geiger K; Quinkler M; Fassnacht M; Nitschke R; Rückauer KD; Beuschlein F
Endocrinology; 2008 Mar; 149(3):1314-22. PubMed ID: 18063677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
